Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines-Reference-Cited by-同舟云学术

Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines

Published:2012-05 Issue:2 Volume:498 Page:300-307
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Salem Sameer D.,Abou-Tarboush Faisal M.,Saeed Nadeem M.,Al-Qadasi Waheeb D.,Farah M. Abul,Al-Buhairi Muneera,Al-Harbi Najla,Alhazza Ibrahim,Alsbeih Ghazi

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference50 articles.

1. Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial—SAKK 44/00-CECOG/PAN.1.3.001;Bernhard;J. Clin. Oncol.,2008

2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J. Clin. Oncol.,1997

3. Role of p53 in apoptosis;Canman;Adv. Pharmacol.,1997

4. Modulation of drug cytotoxicity by reintroduction of wild-type p53 gene (Ad5CMV-p53) in human pancreatic cancer;Cascalló;Cancer Gene Ther.,2000

5. Enhancement of gemcitabine-induced apoptosis by restoration of p53 function in human pancreatic tumors;Cascalló;Oncology,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding cell death signalling: Impact on the response of breast cancer cells to approved therapies;Life Sciences;2024-04

2. Cytotoxicity and Radiosensitizing Potentials of Pilosulin-3, a Recombinant Ant Venom, in Breast Cancer Cells;Toxins;2023-12-15

3. p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons;Diagnostics;2022-12-05

4. The COL11A1/Akt/CREB signaling axis enables mitochondrial-mediated apoptotic evasion to promote chemoresistance in pancreatic cancer cells through modulating BAX/BCL-2 function;Journal of Cancer;2021

5. Modulating the Radiation Response for Improved Outcomes in Breast Cancer;JCO Precision Oncology;2021-01